Form 4: Keurig Dr Pepper Director Sells Over 200,000 Shares Under Pre-Arranged Trading Plan

Keurig Dr Pepper Inc. Director Robert James Gamgort sold 208,000 shares of common stock for approximately $33.1 per share, executed under a Rule 10b5-1 trading plan.

Summary

• Robert James Gamgort, a Director of Keurig Dr Pepper Inc. (KDP), disposed of 208,000 shares of common stock.
• The transaction occurred on June 2, 2025.
• The shares were sold at a weighted average price of $33.1 per share, with individual sales ranging from $32.82 to $33.50.
• This sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Gamgort on October 30, 2024.
• Following this transaction, Mr. Gamgort directly beneficially owns 2,638,490 shares and indirectly owns 574,900 shares through a 2023 Trust and 171,821 shares through a 2024 Trust.

Sentiment

Score: 4

Explanation: The sale of a significant number of shares by a director, while executed under a pre-arranged 10b5-1 plan, still represents a reduction in insider ownership. This is generally viewed with slight caution by investors, though the pre-planned nature reduces the immediate negative implication of a discretionary sale.

Positives

• The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, non-public information and is a scheduled liquidity event.

Negatives

• A significant sale of 208,000 shares by a director reduces insider ownership, which can sometimes be perceived negatively by investors as it might suggest a lack of confidence, even if pre-planned.

Future Outlook

NA

Industry Context

This Form 4 filing is specific to an insider transaction at Keurig Dr Pepper Inc. and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May view the reduction in insider ownership with slight concern, though the 10b5-1 plan suggests a pre-determined liquidity event rather than a reaction to new negative information.

Key Dates

Recommendation

Keywords

Keurig Dr Pepper, KDP, Insider Trading, Form 4, Stock Sale, Director, Robert James Gamgort, 10b5-1 Plan, Equity Transaction, Beneficial Ownership